Ceftazidime
TAZICEF
Cephalosporin Antibacterial
NADAC/unit
$3.7045
No Shortage
Tier 1: 115.5%
PA Req: 48.6%
2 Manufacturers
8 ANDAs
Ceftazidime kills bacteria by disrupting cell wall synthesis, used for a range of infections.
vs. brand TAZICEF: Generic saves up to 63% per unit
Active Shortages
2025-11-14 Discontinuation of the manufacture of the drug, Hospira, Inc., a Pfizer Company
2025-11-14 Discontinuation of the manufacture of the drug, Hospira, Inc., a Pfizer Company
Generic Manufacturers
ACS DOBFAR SPAHOSPIRA INC
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.